Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. …
Somewhere along the line we forgot how to value seven large companies. We knew they were better than almost all of the other companies out there. We knew that their managements were incredibly good and their prospects enormous. But looking back, we stopped caring at what price we bought these …
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday released prices for the first 10 prescription drugs that were subject to landmark …
Here are the biggest calls on Wall Street on Wednesday: Wolfe downgrades PulteGroup to peer perform from outperform Wolfe says the homebuilder is overvalued. “Valuation is the key driver of our PHM downgrade, while the company’s elevated exposure to Florida and balanced consumer segmentation likely limits upside to our estimates.” …
Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. The Nasdaq led the way down, losing 3.35% on the week, followed by the Dow Jones Industrial’s decline of 2.1%, and the S & P 500’s 2.06% drop. It …
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The list …
GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. The stock then reversed higher as the post-earnings call got underway. Management made it clear that they think that weakness in China is temporary and see many other levers available to grow earnings. Revenue …
Alphabet on Thursday delivered largely better-than expected earnings results that showed the search and cloud giant is finally on better footing in the fast-growing AI space. Total revenue in the three months ended June 30 rose 13.6% year over year to $84.74 billion, outpacing the $84.19 billion expected, according to …
If you still doubt the power that the biggest stocks have over this market, Friday’s performance should dispel it: Meta Platforms added $29.95, or 5.8%, bumping its gain this year to more than 52.8%. Amazon rallied $2.41, or 1.2%, and is now up roughly 31.6% in 2024. Alphabet increased $4.78, …
As investors peer into the future to envision which industries are ripe to be reshaped and energized by artificial intelligence, drug discovery is fast emerging as an obvious choice. Each new drug that hits the market is the product of billions of dollars in investment, often taking at least a …
